Bioinformatics Market by Solutions & Services (Knowledge Management, Platforms, Sequence Analysis, Services, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Healthcare, Veterinary, Agriculture) - Global Forecast to 2030

Bioinformatics Market by Solutions & Services (Knowledge Management, Platforms, Sequence Analysis, Services, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Healthcare, Veterinary, Agriculture) - Global Forecast to 2030


Bioinformatics Market by Solutions & Services (Knowledge Management, Platforms, Sequence Analysis, Services, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Healthcare, Veterinary, Agriculture)—Global Forecast to 2030

The bioinformatics market is expected to reach $27.98 billion by 2030, at a CAGR of 13.3% from 2023 to 2030.

With extensive primary and secondary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the bioinformatics market is attributed to the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. However, interoperability limitations in bioinformatics analytical platforms due to multiple data types restrain the growth of this market. Furthermore, untapped markets in emerging economies, growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture are expected to generate growth opportunities for the players operating in this market. However, data privacy and confidentiality concerns and the shortage of skilled bioinformaticians are major challenges for market stakeholders.

Based on solutions & services, the bioinformatics market is segmented into knowledge management software, bioinformatics platforms, and services. In 2023, the knowledge management software segment is expected to account for the largest share of the bioinformatics market. Knowledge management software helps in identifying, organizing, storing, and disseminating biological information within or across organizations. Knowledge management tools help consolidate data and information. It also serves as a comprehensive data hub, providing a centralized repository for various types of biological information, including genomics, proteomics, metabolomics, and clinical data. Expanding genomic datasets, growing adoption of precision medicine, growing investments in pharmaceutical R&D, and growing research in the application of genomics for several fields, including agriculture, clinical decision-making, and predictive medicine, were the factors contributing to the segment’s large share.

Based on application, the bioinformatics market is segmented into genomics, chemoinformatics, proteomics, transcriptomics, metabolomics, and other applications. In 2023, the genomics segment is expected to account for the largest share of the market. Genomics involves investigating the complete or partial genetic and epigenetic sequence information of organisms, with the aim of comprehending both the arrangement and the operational aspects of these sequences. This segment's large market share is attributed to the growing amount of genomics data being generated, the application of genomics in chronic disease management, and the growing prevalence of chronic diseases.

Based on industry, the bioinformatics market is segmented into healthcare, agriculture, veterinary, and other industries. In 2023, the healthcare segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the wide applications of bioinformatics in the biotechnology and pharmaceutical industry, the growth of the pharmaceutical and biotech industry, supportive initiatives for the growth of pharmaceutical and biotech companies, the growing prevalence of chronic diseases, and growing adoption of precision medicine. Precision medicine is a tailored treatment approach as per an individual’s genetic makeup, making the treatments more effective while preventing adverse drug reactions. The growing prevalence of chronic diseases like cancer is leading to the adoption of precision medicine treatment. For instance, in 2022, OncoDNA (Belgium), a precision medicine company, collaborated with Eli Lilly Italia (Italy) to provide biomarker testing for thyroid cancer in Italy. Under this collaboration, they offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to help clinicians identify gene alterations in tumors and link patients with targeted therapies.

An in-depth analysis of the geographical scenario of the bioinformatics market provides detailed qualitative and quantitative insights into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, along with the coverage of major countries in each region. Asia-Pacific is slated to register the highest CAGR during the forecast period. The market growth in this region is attributed to the growing pharmaceutical and biotech industry, growth in genomics research, growing use of genetic engineering in the agriculture sector, favorable government initiatives to develop novel bioinformatics tools, and growing clinical trials in the region. Bioinformatic analyses are used for the data generated from pre-clinical and clinical trials as the amount of data generated is huge, and the integration of this generated biological data is necessary to interpret the results. The number of clinical trials in Malaysia is expected to increase to 3,779 from 1,400 clinical trials in 2019 (Source: Clinical Trials Malaysia).

Some of the key players operating in the global bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).

Scope of the Report

Bioinformatics Market Assessment, by Solutions & Services


Knowledge Management Software
Bioinformatics Platforms
Sequence Analysis & Alignment Platforms
Functional & Structural Analysis Platforms
Other Bioinformatic Platforms

(Other bioinformatic platforms include Pathway Analysis, Network Analysis, Phylogenetic Analysis, Data Visualization, Among others)
Services
Data Storage and Database Management Services
Data Analysis Services

Bioinformatics Market Assessment, by Application

Genomics
Chemoinformatics
Proteomics
Transcriptomics
Metabolomics
Other Applications

(Other applications include system biology and computational biology, among others)

Bioinformatics Market Assessment, by Industry


Healthcare
Agriculture
Veterinary
Other Industries

(Other industries include environmental sciences, forensics sciences, and energy, among others)

Bioinformatics Market Assessment, by Geography


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Brazil
Mexico
Rest of Latin America (RoLATAM)
Middle East & Africa

Bioinformatics Market - Report Summary
Report MetricsDetails
Years Considered2021 - 2030
Base Year2022
Forecast Period2023-2030
Page Count198
Units ReferencedValue (USD Million)
Segments/Key TopicsSolutions & Services, Application, Industry
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Companies MentionedIllumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).


FAQs About the Report

What is the focus of the bioinformatics market study?

The bioinformatics market report covers market sizes & forecasts for knowledge management software, bioinformatics platforms, and services. The bioinformatics market study includes the value analysis of various segments and subsegments of the bioinformatics market at the regional and country levels.

What is the revenue generated from the sales of bioinformatics solutions & services across the globe? At what rate is the demand expected to grow for the next 5–7 years?

The bioinformatics market is projected to reach $27.98 billion by 2030, at a CAGR of 13.3% from 2023 to 2030.

Which solutions & services segment is estimated to hold the major share of the market in 2023?

The knowledge management software segment is estimated to account for the largest share of the bioinformatics market in 2023. Moreover, this segment is expected to record the highest CAGR during the forecast period.

Which applications segment is projected to gain more traction in the global bioinformatics market?

Based on application, the proteomics segment is projected to gain more traction in the bioinformatics market.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global bioinformatics market?

The high growth of the bioinformatics market is mainly attributed to the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. Moreover, untapped markets in emerging economies, growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture offer market growth opportunities.

Who are the major players operating in the global bioinformatics market?

The key players operating in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

The emerging Asian-Pacific countries are expected to offer significant growth opportunities for the vendors in this market due to the growing pharmaceutical and biotech industry, growth in genomics research, growing use of genetic engineering in the agriculture sector, and favorable government initiatives in Asian countries to develop novel bioinformatics tools.


1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.1. Market Share Analysis
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Drivers
4.2.1.1.1. Growth of the Biotech and Pharmaceutical Industries
4.2.1.1.2. Initiatives Supporting Genomics Research
4.2.1.1.3. Rising Need to Develop Novel Drugs/Drug Molecules
4.2.1.2. Restraints
4.2.1.2.1. Interoperability Limitations in Bioinformatics Analytical Platforms Due to Multiple Data Types
4.2.1.3. Opportunities
4.2.1.3.1. Untapped Markets in Emerging Economies
4.2.1.3.2. Growing Clinical Applications of Genomic Technologies
4.2.1.3.3. Increasing Use of Bioinformatics in Agriculture
4.2.1.4. Challenges
4.2.1.4.1. Shortage of Skilled Bioinformaticians
4.2.1.4.2. Data Privacy and Confidentiality Concerns
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Integration of Artificial Intelligence (AI) and Machine Learning with Bioinformatics
4.3.1.1. AI in Genomics and Sequence Analysis
4.3.1.2. AI-driven Drug Discovery
4.3.1.3. Proteomics and AI Applications
4.3.1.4. AI for Personalized Medicine
4.4. Case Studies
4.4.1. Integration of the Client’s Multi-Disease Platform into A Single Solution
4.4.2. Provision of a Connected Analytic Solution for NGS Workflow Scaling Challenges
4.4.3. Facilitating Faster Processing and Lowering Plasmid Analysis Costs
4.5. Regulatory Analysis
5. Bioinformatics Market Assessment—by Solutions & Services
5.1. Overview
5.2. Knowledge Management Software
5.3. Bioinformatics Platforms
5.3.1. Sequence Analysis & Alignment Platforms
5.3.2. Functional & Structural Analysis Platforms
5.3.3. Other Bioinformatics Platforms
5.4. Services
5.4.1. Data Storage & Database Management Services
5.4.2. Data Analysis Services
6. Bioinformatics market assessment—by Application
6.1. Overview
6.2. Genomics
6.3. Chemoinformatics
6.4. Proteomics
6.5. Transcriptomics
6.6. Metabolomics
6.7. Other Applications
7. Bioinformatics market assessment—by Industry
7.1. Overview
7.2. Healthcare
7.3. Agriculture
7.4. Veterinary
7.5. Other Industries
8. Bioinformatics Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest Of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest Of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
9.5.1. Thermo Fisher Scientific Inc. (U.S.)
9.5.2. Eurofins Genomics LLC (Germany)
9.5.3. Revvity, Inc. (U.S.)
9.5.4. Agilent Technologies, Inc. (U.S.)
9.5.5. Illumina, Inc. (U.S.)
9.5.6. F. Hoffmann–La Roche Ltd. (Switzerland)
9.5.7. Qiagen N.V. (Netherlands)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Thermo Fisher Scientific, Inc.
10.2. Eurofins Genomics LLC (Subsidiary of Eurofins Scientific SE)
10.3. Revvity, Inc. (Previously Known as Perkinelmer, Inc.)
10.4. Agilent Technologies, Inc.
10.5. Illumina, Inc.
10.6. Qiagen N.V.
10.7. Dnanexus, Inc.
10.8. Dassault Systemes SE
10.9. Azenta, Inc.
10.10. F. Hoffmann-La Roche Ltd
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
Table 1 Investments and Funding to Support Genomics Research
Table 2 Bioinformatics: Standards and Compliance Guidelines
Table 3 Global Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 4 Global Bioinformatics Knowledge Management Software Market, By Country/Region, 2021–2030 (USD Million)
Table 5 Global Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 6 Global Bioinformatics Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 7 Global Sequence Analysis & Alignment Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 8 Global Functional & Structural Analysis Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 9 Global Other Bioinformatics Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 10 Global Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 11 Global Bioinformatics Services Market, By Country/Region, 2021–2030 (USD Million)
Table 12 Global Data Storage & Database Management Services Market, By Country/Region, 2021–2030 (USD Million)
Table 13 Global Data Analysis Services Market, By Country/Region, 2021–2030 (USD Million)
Table 14 Global Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 15 Global Bioinformatics Market for Genomics, By Country/Region, 2021–2030 (USD Million)
Table 16 Global Bioinformatics Market for Cheminformatics, By Country/Region, 2021–2030 (USD Million)
Table 17 Number of People with Diabetes Aged 20–79, By Region, 2021 Vs. 2030 Vs. 2045 (In Thousands)
Table 18 Global Bioinformatics Market for Proteomics, By Country/Region, 2021–2030 (USD Million)
Table 19 Estimated Number of New Cancer Cases, By Type (2020 Vs. 2030)
Table 20 Global Bioinformatics Market for Transcriptomics, By Country/Region, 2021–2030 (USD Million)
Table 21 Global Bioinformatics Market for Metabolomics, By Country/Region, 2021–2030 (USD Million)
Table 22 Global Bioinformatics Market for Other Applications, By Country/Region, 2021–2030 (USD Million)
Table 23 Global Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 24 Number of Clinical Trials 2019-2021
Table 25 Global Bioinformatics Market for Healthcare, By Country/Region, 2021–2030 (USD Million)
Table 26 Global Bioinformatics Market for Agriculture Industry, By Country/Region, 2021–2030 (USD Million)
Table 27 Global Meat Consumption by Type and Region, 2020 Vs. 2026 (Thousand Tonnes)
Table 28 Global Bioinformatics Market for Veterinary, By Country/Region, 2021–2030 (USD Million)
Table 29 Global Bioinformatics Market for Other Industries, By Country/Region, 2021–2030 (USD Million)
Table 30 Global Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 31 North America: Bioinformatics Market, By Country, 2021–2030 (USD Million)
Table 32 North America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 33 North America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 34 North America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 35 North America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 36 North America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 37 U.S.: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 38 U.S.: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 39 U.S.: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 40 U.S.: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 41 U.S.: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 42 Canada: Bioinformatics Market, By Solutions & Services, 2021–2030(USD Million)
Table 43 Canada: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 44 Canada: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 45 Canada: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 46 Canada: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 47 Europe: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 48 Europe: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 49 Europe: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 50 Europe: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 51 Europe: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 52 Europe: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 53 Germany: Bioinformatics Market, By Solutions & Services, 2021–2030(USD Million)
Table 54 Germany: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 55 Germany: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 56 Germany: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 57 Germany: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 58 France: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 59 France: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 60 France: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 61 France: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 62 France: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 63 U.K. Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 64 U.K. Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 65 U.K. Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 66 U.K. Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 67 U.K. Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 68 Italy: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 69 Italy: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 70 Italy: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 71 Italy: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 72 Italy: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 73 Spain: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 74 Spain: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 75 Spain: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 76 Spain: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 77 Spain: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 78 Estimated Number of New Cancer Cases, By Country, 2020 Vs. 2030
Table 79 Rest of Europe: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 80 Rest of Europe: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 81 Rest of Europe: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 82 Rest of Europe: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 83 Rest of Europe: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 84 Asia-Pacific: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 85 Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 86 Asia-Pacific: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 87 Asia-Pacific: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 88 Asia-Pacific: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 89 Asia-Pacific: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 90 China: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 91 China: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 92 China: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 93 China: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 94 China: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 95 India: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 96 India: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 97 India: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 98 India: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 99 India: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 100 Japan: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 101 Japan: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 102 Japan: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 103 Japan: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 104 Japan: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 105 Rest of Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 106 Rest of Asia-Pacific: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 107 Rest of Asia-Pacific: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 108 Rest of Asia-Pacific: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 109 Rest of Asia-Pacific: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 110 Latin America: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 111 Latin America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 112 Latin America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 113 Latin America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 114 Latin America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 115 Latin America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 116 Brazil: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 117 Brazil: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 118 Brazil: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 119 Brazil: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 120 Brazil: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 121 Mexico: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 122 Mexico: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 123 Mexico: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 124 Mexico: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 125 Mexico: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 126 Rest of Latin America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 127 Rest of Latin America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 128 Rest of Latin America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 129 Rest of Latin America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 130 Rest of Latin America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 131 Middle East & Africa: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 132 Middle East & Africa: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 133 Middle East & Africa: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 134 Middle East & Africa: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 135 Middle East & Africa: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 136 Recent Developments, By Company, 2020-2023
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Bioinformatics Market, By Solution & Service, 2023 Vs. 2030 (USD Million)
Figure 8 Global Bioinformatics Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 9 Global Bioinformatics Market, By Industry, 2023 Vs. 2030 (USD Million)
Figure 10 Global Bioinformatics Market, By Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 U.S.: Adoption of Genetically Engineered Crops, 2018 Vs. 2022
Figure 13 Pharmaceutical R&D Expenditures in The U.S., Europe, China, And Japan, 2010 Vs. 2021 (USD Billion)
Figure 14 U.S.: Number of Personalized Medicines on The Market, 2008-2020
Figure 15 Global Bioinformatics Market, By Solutions & Services, 2023 Vs. 2030 (USD Million)
Figure 16 Global Bioinformatics Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 17 Applications of Metabolomics
Figure 18 Global Bioinformatics Market, By Industry, 2023 Vs. 2030 (USD Million)
Figure 19 Global Bioinformatics Market, By Geography, 2023 Vs. 2030 (USD Million)
Figure 20 North America: Bioinformatics Market Snapshot
Figure 21 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 22 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 23 Europe: Bioinformatics Market Snapshot
Figure 24 RoE: Pharmaceutical R&D Expenditure, 2020
Figure 25 Asia-Pacific: Bioinformatics Market Snapshot
Figure 26 Clinical Trial Activities in Malaysia, 2015-2025
Figure 27 Latin America: Bioinformatics Market Snapshot
Figure 28 Israel: National Committee for Transgenic Plants - Authorized Experiments, 2016-2021
Figure 29 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 30 Bioinformatics Market: Competitive Benchmarking, By Solution & Services
Figure 31 Bioinformatics Market: Competitive Benchmarking, By Region
Figure 32 Competitive Dashboard Bioinformatics Market
Figure 33 Global Bioinformatics Market Share Analysis, By Key Players, 2022 (%)
Figure 34 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 35 Eurofins Scientific SE.: Financial Overview (2022)
Figure 36 PerkinElmer, Inc.: Financial Overview (2022)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 38 Illumina, Inc.: Financial Overview (2022)
Figure 39 Qiagen N.V.: Financial Overview (2022)
Figure 40 Dassault Systemes SE: Financial Overview (2022)
Figure 41 Azenta, Inc.: Financial Overview (2022)
Figure 42 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings